MarketPeel
Insider Trading Intelligence
DJ

Daniel C. Javitt

NRXP
10% OWNER · NRX PHARMACEUTICALS, INC. · CIK 0001864534
FILING MIX · LIFETIME8%/92%
BUYS
1
SELLS
12
TOTAL VALUE
$1.35M
COMPANIES
1
ACTIVE SINCE
May 2021
HOLDINGS NOW
9,634,793
AVG SELL PX
$0.92
TRADE KIND
SHOWING 13 / 13
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
9 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Daniel C. Javitt, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d9+55.56%-5.78%-2.71%-3.07%-2.62%
14d9+55.56%-1.45%-1.97%+0.52%-1.16%
30d9+77.78%-8.87%-3.86%-5.01%-7.78%
60d9+33.33%+7.79%-0.89%+8.68%+8.48%
90d9+55.56%-6.21%-0.96%-5.24%-1.02%
180d9+55.56%+18.47%+2.29%+16.18%-38.99%
1y9+88.89%-48.43%+11.49%-59.92%-79.31%
2y9+100.00%-73.14%+44.87%-118.01%-141.16%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NRXP · 9,634,793 shares · as of Nov 30, 2022
03,492,9666,985,93210,478,89813,971,8642022SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2022
2022
2022
2022
FLOW · 1 buys / 12 sellsCOVERAGE · 7 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
NRXP
NRX PHARMACEUTICALS, INC.
SALE
8,441$1.50$12.7K9,634,793Nov 30, 2022Dec 1, 2022View →
NRXP
NRX PHARMACEUTICALS, INC.
SALE
13,730$1.50$20.7K9,643,234Nov 29, 2022Dec 1, 2022View →
NRXP
NRX PHARMACEUTICALS, INC.
SALE
33,018$1.05$34.7K9,656,964Nov 17, 2022Nov 18, 2022View →
NRXP
NRX PHARMACEUTICALS, INC.
SALE
133,719$1.02$136.4K9,689,982Nov 16, 2022Nov 18, 2022View →
NRXP
NRX PHARMACEUTICALS, INC.
SALE
49,200$1.01$49.5K9,823,701Nov 11, 2022Nov 15, 2022View →
NRXP
NRX PHARMACEUTICALS, INC.
SALE
784,063$1.01$791.4K9,872,901Jul 29, 2022Aug 2, 2022View →
NRXP
NRX PHARMACEUTICALS, INC.
SALEGRANT
Gift
2,000,00010,656,964Jul 1, 2022Jul 5, 2022View →
NRXP
NRX PHARMACEUTICALS, INC.
SALE
86,459$0.65$55.9K12,656,964Jun 7, 2022Jun 7, 2022View →
NRXP
NRX PHARMACEUTICALS, INC.
SALE
115,657$0.67$76.9K12,743,423Jun 6, 2022Jun 7, 2022View →
NRXP
NRX PHARMACEUTICALS, INC.
SALE
243,596$0.70$171.1K12,859,080Jun 3, 2022Jun 7, 2022View →
NRXP
NRX PHARMACEUTICALS, INC.
SALEGRANT
Gift
434,59413,102,676Jul 16, 2021Nov 2, 2021View →
NRXP
NRX PHARMACEUTICALS, INC.
SALEGRANT
Gift
434,59413,537,270Jul 16, 2021Nov 2, 2021View →
NRXP
NRX PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
13,971,86413,971,864May 24, 2021Jun 10, 2021View →
Other insiders · NRXP
Loading peer insiders…
About this filer
CIK 0001864534
ROLE
10% Owner
PRIMARY
NRXP
COMPANIES
1
ACTIVE SINCE
May 2021
MARKETPEEL · /INSIDER/0001864534DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback